About Us

WHAT WE DO

IAG, Image Analysis Group is a unique partner to life sciences companies. Our goal is to accelerate novel drug developments, by using the right analytical tools and a modern trial infrastructure.

At IAG, we are committed to helping our biotech and pharma partners to efficiently develop novel life-changing medicines, accelerating their R&D pipelines through advanced analytics, IAG’s technology solutions and imaging contract research services.

IAG’s foundation is in software development, use of Artificial Intelligence and data sciences applied to medical imaging.

Today, IAG leads the industry when it comes to optimizing clinical trial designs with imaging-based methodologies that can accelerate go / no-go efficacy decisions for emerging therapeutics and enrich patient selection in musculoskeletal, oncology, immunology, rheumatology, CNS and rare disease trials.

IAG’s proprietary platform DYNAMIKA, developed to maximize efficiencies of handling imaging data in multi-centre clinical trials is used by blue-chip pharmaceutical companies, CROs, biotechnology companies, and academics world-wide.

Smart use of novel approaches for central image review and our modern trial infrastructure ensure the speed and cost-effectiveness of phase I-VI trial execution, while delivering insights about novel mechanisms of action and patients’ response, in real-time.

IAG’s teams together with our world-class Scientific Advisory Board closely work with our life science partners to address their goals of smart trial design, efficient execution and transparent processes.

We are here to create successful partnerships and to see more patients cured with the drugs, that we can help you to develop.

STRATEGY

Combining extensive expertise in medical imaging, proprietary analytics tools and multi-sites trials optimized cloud-based platform to help our clients in their innovative drugs development journey.

TRIAL SOLUTIONS

Driven by the objective of facilitating clinical trials, IAG’s Team is supporting each step of the process to ensures optimized processes, fast projects executions and better outcomes.

LASTEST NEWS

Constantly working to deliver our best to reach the goals of our sponsors and partners, IAG’s team is also traveling around the world to meet you and share together the medicine of tomorrow.

Imaging Services in Clinical Trials

IAG’s project, site support and data teams are located in the USA, UK, EU and Asia. We strategically use radiology imaging, AI and technology to accelerate drug development and lower investment risks. Whether you are entering a phase I/II and need early robust efficacy data or preparing a global phase 3 trial, our science, operations and technology teams will work with you to develop the right solution.

DYNAMIKA, Image Management Platform

is IAG’s proprietary enterprise-scale cloud-based platform for imaging processing and data management. It works across multi-centre trial settings to enable central imaging review.​ This one comprehensive software system controls trial progress, conducts central reads and, when needed, it can be integrated with AI tools for earlier read-outs and decision support.

 

Publications

Since 2007, many articles were published by IAG’s team and advisory board to cover scientific discoveries, technology break-throughs and special cases. We list here some critically important papers and abstracts.

Quality Management

Rigorous quality standards, our products and processes adhere to ISO13485 and other industry standard requirements. Our Quality Management System is certified by the British Standards Institute (BSI).